Drug and Alcohol Testing


  • Minnesota Fentanyl Deaths Soared in 2017

    "This dramatic increase shows that the opioid epidemic in Minnesota has also become a fentanyl public health crisis," said Minnesota Health Commissioner Jan Malcolm. "These data confirm that Minnesotans addicted to opioids may unknowingly be exposing themselves to far greater and more deadly risks than they know." More News

  • Analysis Finds Workforce Drug Positivity at Highest Rate in a Decade

    Analysis Finds Workforce Drug Positivity at Highest Rate in a Decade

    The national positivity rate for the combined American workforce remained at 4.2 percent in 2017, the same rate as 2016 but an increase over the 3.5 percent positivity rate from 2012, a 30-year low. Quest Diagnostics' analysis also suggests changing patterns of drug use, with cocaine, amphetamines, and marijuana positivity rising in some areas of the United States and prescription opiate positivity rates declining nationally. More News

  • Random Drug Screening Urged for FECA Program Patients

    During a Capitol Hill hearing May 8 on the opioid epidemic's implications for the Federal Employees' Compensation Act, one witness said the program must build an approach that includes random screening for all patients who are prescribed opioids. More News

  • 2018 SHRM Conference Includes Sessions on Rx Overuse, Workplace Depression

    The June 17-20 conference will include more than 230 concurrent sessions on topics such as prescription drug overuse, workplace depression, bullying and harassment, workplace violence, health care reform, financial wellness for young workers, and more. More News

  • Michigan Reports Progress Against Opioid Use

    The number of opioid prescriptions issued in 2071 was 10.7 percent below the number in 2015, and the overall number of schedules 2-5 controlled substance prescriptions dispensed fell by 7.1 percent during the same period. More News

  • FRA Schedules Three Seminars on Training, Drug Testing Rules

    The Part 219 presentation will address the expanded scope of FRA's drug and alcohol control regulations to cover maintenance of way employees. The Part 243 presentation will provide an overview of program compliance requirements and address significant upcoming implementation deadlines. More News



  • Marijuana Safety Road Trip

    NFPA Journal's Jesse Roman takes a trip to Colorado in 2016 to report on the the burgeoning commercial marijuana industry and how public agencies are battling to ensure that marijuana grow and extraction facilities are safe for employees, firefighters, and the public.

  • Boating Safety PSA

    This boating safety public service announcement detailing various important topics to keep everyone safe on the water was created by U.S. Coast Guard Auxiliarist David Glaser.

  • Bath Salts: It's not a fad... It's a Nightmare

    Bath salts are a non-regulated designer drug comprised of a synthetic cathinone, or amphetamine, that can have dangerous and debilitating effects on those who use them. The adverse health effects from bath salt use can range from agitation to lack of appetite, kidney failure, muscle spasms, severe paranoid delusions, and psychosis. Several cases of long-term patient hospitalization and suicide have been reported. For more information from Navy Medicine on Synthetic Drugs and your health, visit http://go.usa.gov/gwhW.